Novo Nordisk A/S
NOVO-B
Classement en actions
#105
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Prix de l'action
$39.75
Capitalisation boursière
$175.44B
Changement (1 jour)
1.32%
Changement (1 an)
-25.55%
Pays
DK
Échange Novo Nordisk A/S (NOVO-B)
Catégorie
Healthcare
Nombre d'actions en circulation pour Novo Nordisk A/S (NOVO-B)
Nombre d'actions en circulation au December 2025: 4.44B
Selon les derniers rapports financiers et le cours de l'action de Novo Nordisk A/S, le nombre actuel d'actions en circulation est de 4.44B. À la fin de December 2024, l'entreprise avait 4.45B actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Novo Nordisk A/S (NOVO-B) de 2001 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 4.44B | 0.01% |
| 2025 | 4.44B | -0.24% |
| 2024 | 4.45B | -0.64% |
| 2023 | 4.48B | -1.06% |
| 2022 | 4.53B | -1.38% |
| 2021 | 4.59B | -1.58% |
| 2020 | 4.67B | -1.70% |
| 2019 | 4.75B | -1.87% |
| 2018 | 4.84B | -2.17% |
| 2017 | 4.95B | -2.24% |
| 2016 | 5.06B | -1.59% |
| 2015 | 5.14B | -1.95% |
| 2014 | 5.24B | -2.15% |
| 2013 | 5.36B | -2.27% |
| 2012 | 5.48B | -3.02% |
| 2011 | 5.65B | -2.60% |
| 2010 | 5.81B | -3.12% |
| 2009 | 5.99B | -3.02% |
| 2008 | 6.18B | -2.08% |
| 2007 | 6.31B | -1.77% |
| 2006 | 6.42B | -2.19% |
| 2005 | 6.57B | -2.89% |
| 2004 | 6.76B | -1.01% |
| 2003 | 6.83B | -1.40% |
| 2002 | 6.93B | 0.61% |
| 2001 | 6.89B | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 892.40M | -79.92% |
US
|
|
| 2.45B | -44.92% |
US
|
|
| 1.77B | -60.15% |
US
|
|
| 0.00 | -100.00% |
US
|
|
| 796.00M | -82.09% |
CH
|
